NON-INVASIVE MONITORING OF EGFR MUTATIONS IN NONSMALL CELL LUNG CANCER (NSCLC) DURING TARGETED THERAPY: STATE OF THE ART AND OUR EXPERIENCE. Вопр. онкол. [Internet]. 2016 Dec. 15 [cited 2026 Oct. 14];62(4):513-8. Available from: https://voprosyonkologii.ru/index.php/journal/article/view/324